Florian Brand files SEC Form 4 disclosures for ATAI Life Sciences N.V.. They have made 5 open-market trades across 1 company since 2021, most recently 2024-05-16.
CIK 0001860682
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $220K since 2021, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ATAI | 328,697 | $2.4M |
Shares reported on the most recent Form 4, priced at the 2024-05-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATAI | SELL | 2024-05-16 | 2024-05-20 | $1.92 | $581K | -9.8% | -23.6% | -24.7% |
| ATAI | BUY | 2023-11-16 | 2023-11-20 | $1.16 | $23K | +1.8% | +20.0% | +82.7% |
| ATAI | BUY | 2023-09-13 | 2023-09-14 | $1.45 | $58K | -13.6% | -10.9% | -17.7% |
| ATAI | BUY | 2023-03-29 | 2023-03-30 | $1.48 | $104K | +5.2% | +14.5% | -5.2% |
| ATAI | BUY | 2021-06-22 | 2021-06-24 | $15.00 | $35K | -0.8% | -7.9% | -7.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.